Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 1Other hematologic neoplasm 1Myeloid 1Lymphoid 1

Conditions

Neoplasms, Plasma Cell 1Myeloproliferative Disorders 1Myelodysplastic Syndromes 1Multiple Myeloma 1Lymphoma, Non-Hodgkin 1Lymphoma 1Leukemia 1Infections 1Hodgkin Disease 1

Interventions

Doxorubicin 26Bleomycin 24Vinblastine 21Dacarbazine 20Vincristine 18Cyclophosphamide 16Radiotherapy 14Etoposide 13Prednisone 12Filgrastim 11ABVD protocol 10Procarbazine 8Peripheral Blood Stem Cell Transplantation 7Granulocyte Colony-Stimulating Factor 7Brentuximab Vedotin 6pegfilgrastim 5Methotrexate 5Dexamethasone 5Cytarabine 5Cyclosporine 5Prednisolone 4Mycophenolic Acid 4Mechlorethamine 4Cyclosporins 4Cisplatin 4Whole-Body Irradiation 3Vinorelbine 3Radiation 3Ifosfamide 3Epoetin Alfa 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 3 × Hodgkin Disease × Nystatin × Clear all
NCT00002742 2013-03-26

Antifungal Therapy for Fever and Neutropenia in Patients Receiving Treatment for Hematologic Cancer

National Cancer Institute (NCI)

Phase 3 Completed
LymphoidMyeloidOther hematologic neoplasmPlasma cell

Hodgkin Disease, Infections, Leukemia, Lymphoma, Lymphoma, Non-Hodgkin, Multiple Myeloma, Myelodysplastic Syndromes, Myeloproliferative Disorders, Neoplasms, Plasma Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡